Circular RNA vaccines against SARS-CoV-2 and emerging variants

As the emerging variants of SARS-CoV-2 continue to drive the worldwide pandemic, there is a constant demand for vaccines that offer more effective and broad-spectrum protection. Here, we report a circular RNA (circRNA) vaccine that elicited potent neutralizing antibodies and T cell responses by expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Liang, Yi, Zongyi, Shen, Yong, Lin, Liangru, Chen, Feng, Xu, Yiyuan, Wu, Zeguang, Tang, Huixian, Zhang, Xiaoxue, Tian, Feng, Wang, Chunhui, Xiao, Xia, Dong, Xiaojing, Guo, Li, Lu, Shuaiyao, Yang, Chengyun, Tang, Cong, Yang, Yun, Yu, Wenhai, Wang, Junbin, Zhou, Yanan, Huang, Qing, Yisimayi, Ayijiang, Liu, Shuo, Huang, Weijin, Cao, Yunlong, Wang, Youchun, Zhou, Zhuo, Peng, Xiaozhong, Wang, Jianwei, Xie, Xiaoliang Sunney, Wei, Wensheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971115/
https://www.ncbi.nlm.nih.gov/pubmed/35460644
http://dx.doi.org/10.1016/j.cell.2022.03.044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971115/
https://www.ncbi.nlm.nih.gov/pubmed/35460644
http://dx.doi.org/10.1016/j.cell.2022.03.044

Ejemplares similares